InvestorsObserver
×
News Home

Can Tempest Therapeutics Inc (TPST) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, November 02, 2023 11:49 AM | InvestorsObserver Analysts

Mentioned in this article

Can Tempest Therapeutics Inc (TPST) Stock Rise to the Top of Healthcare Sector Thursday?

Tempest Therapeutics Inc (TPST) is around the top of the Healthcare sector according to InvestorsObserver. TPST received an overall rating of 57, which means that it scores higher than 57% of stocks. Additionally, Tempest Therapeutics Inc scored a 96 in the Healthcare sector, ranking it higher than 96% of stocks in that sector.

Overall Score - 57
TPST has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on TPST!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 57 would rank higher than 57 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tempest Therapeutics Inc Stock Today?

Tempest Therapeutics Inc (TPST) stock is trading at $3.72 as of 11:48 AM on Thursday, Nov 2, a rise of $0.02, or 0.49% from the previous closing price of $3.70. The stock has traded between $3.63 and $4.00 so far today. Volume today is less active than usual. So far 1,265,664 shares have traded compared to average volume of 19,350,693 shares. Click Here to get the full Stock Report for Tempest Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App